[go: up one dir, main page]

NO982155D0 - FremgangsmÕte for fremstilling av korrekt foldet, biologisk aktivt rekombinant protein - Google Patents

FremgangsmÕte for fremstilling av korrekt foldet, biologisk aktivt rekombinant protein

Info

Publication number
NO982155D0
NO982155D0 NO982155A NO982155A NO982155D0 NO 982155 D0 NO982155 D0 NO 982155D0 NO 982155 A NO982155 A NO 982155A NO 982155 A NO982155 A NO 982155A NO 982155 D0 NO982155 D0 NO 982155D0
Authority
NO
Norway
Prior art keywords
recombinant protein
cells
correctly folded
active recombinant
biologically active
Prior art date
Application number
NO982155A
Other languages
English (en)
Other versions
NO982155L (no
NO320175B1 (no
Inventor
Jan-Gunnar Gustafsson
Johan Ihman
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO982155D0 publication Critical patent/NO982155D0/no
Publication of NO982155L publication Critical patent/NO982155L/no
Publication of NO320175B1 publication Critical patent/NO320175B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19982155A 1995-11-13 1998-05-12 Fremgangsmate for fremstilling av korrekt foldet, biologisk aktivt rekombinant protein eller polypeptid. NO320175B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9504019A SE9504019D0 (sv) 1995-11-13 1995-11-13 Method for production of proteins
PCT/SE1996/001456 WO1997018233A1 (en) 1995-11-13 1996-11-12 Method for producing a correctly folded, biological active recombinant protein

Publications (3)

Publication Number Publication Date
NO982155D0 true NO982155D0 (no) 1998-05-12
NO982155L NO982155L (no) 1998-05-12
NO320175B1 NO320175B1 (no) 2005-11-07

Family

ID=20400188

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982155A NO320175B1 (no) 1995-11-13 1998-05-12 Fremgangsmate for fremstilling av korrekt foldet, biologisk aktivt rekombinant protein eller polypeptid.

Country Status (11)

Country Link
US (1) US6605706B1 (no)
EP (1) EP0952981B1 (no)
JP (1) JP3930051B2 (no)
AT (1) ATE261985T1 (no)
AU (1) AU705192B2 (no)
CA (1) CA2236751C (no)
DE (1) DE69631906T2 (no)
HK (1) HK1023781A1 (no)
NO (1) NO320175B1 (no)
SE (1) SE9504019D0 (no)
WO (1) WO1997018233A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653098B1 (en) * 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
CN1197876C (zh) * 1998-03-31 2005-04-20 通化安泰克生物工程有限公司 含有分子内伴侣样序列的嵌合蛋白及其在胰岛素生产中的应用
GB9913437D0 (en) * 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
FR2820424B1 (fr) * 2001-02-05 2004-01-02 Merieux Oravax Procede de purification de alpa
AR062069A1 (es) 2006-07-14 2008-10-15 Genentech Inc Replegado de proteinas recombinantes
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
WO2022097216A1 (ja) * 2020-11-05 2022-05-12 シミックホールディングス株式会社 組み換えインスリン様成長因子iの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US5231178A (en) 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
EP0600372B1 (de) * 1992-12-02 1997-02-05 Hoechst Aktiengesellschaft Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide

Also Published As

Publication number Publication date
JP2000500023A (ja) 2000-01-11
US6605706B1 (en) 2003-08-12
AU705192B2 (en) 1999-05-20
EP0952981A1 (en) 1999-11-03
AU7659696A (en) 1997-06-05
HK1023781A1 (en) 2000-09-22
CA2236751A1 (en) 1997-05-22
NO982155L (no) 1998-05-12
DE69631906D1 (de) 2004-04-22
JP3930051B2 (ja) 2007-06-13
NO320175B1 (no) 2005-11-07
CA2236751C (en) 2007-01-09
DE69631906T2 (de) 2005-01-20
ATE261985T1 (de) 2004-04-15
EP0952981B1 (en) 2004-03-17
WO1997018233A1 (en) 1997-05-22
SE9504019D0 (sv) 1995-11-13

Similar Documents

Publication Publication Date Title
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
DE69112611D1 (de) Proteinhydrolysate.
ATE299942T1 (de) Verfahren zur herstellung von natürlich gefalteten proteinen durch co-sekretion von molekularen chaperonen
EP1225225A3 (en) Osteogenic devices
DK572487D0 (da) Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
Nakai et al. Amino acid sequence of toxin A from the venom of the Indian cobra (Naja naja)
SE8801701D0 (sv) Production technology based on enzymic method
NO982155D0 (no) FremgangsmÕte for fremstilling av korrekt foldet, biologisk aktivt rekombinant protein
WO2000034474A3 (en) Growth factor homolog zvegf3
AR003407A1 (es) Procedimiento de clonacion de un acido nucleico que codifica una proteina con actividad de delta-5,7-esterol, delta-7-reductasa, procedimiento de preparacion de la proteina, procemiento de reduccion in vitro de un esterol insaturado, procedimiento de produccion de pregnenolona, cepa de levadura transformada y metodo de diagnostico in vitro para la deteccion de la deficiencia de delta-5, 7-esterol, delta-7-reductasa
DE3151738C2 (no)
DE3877035D1 (de) Gentechnologisches verfahren zur herstellung von polypeptiden.
DK218582A (da) Fremgangsmaade til rensning henholdvis berigelse af biologiskeaktive proteiner og hertil egnede midler
Holt et al. Conversion of low-affinity platelet factor 4 to β-thromboglobulin by plasmin and trypsin
Ong et al. Analysis of proteins from different phase variants of the entomopathogenic bacteria Photorhabdus luminescens by two‐dimensional zymography
NO911557L (no) Fremgangsmaate for fremstilling av fremmedproteiner i streptomyceter.
DK0876610T3 (da) Fremgangsmåde og anvendelse af polypeptid i sædcelle-æg-binding til at foröge eller mindske fertilitet
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
ATE183055T1 (de) Verfahren zur aufbereitung von proteinen aus einer proteinhaltigen substanz
DK0725822T3 (da) Fremgangsmåde til rekombinant fremstilling af proteiner i gær
WO1997041207A3 (en) Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector
Yoshikawa et al. Recombinant human glucagon: Large-scale purification and biochemical characterization
Rogol Protein Hormones
KR950032634A (ko) 스트렙토마이세스 써모니트리피컨스 아미노펩티다제를 이용한 천연형 재조합 단백질의 제조방법

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees